[Plasma fibronectin in chronic liver diseases]

Area of Science:

• Hepatology
• Biochemistry
• Clinical Medicine

Background:

• Fibronectin (FN) is a protein involved in cell adhesion and tissue repair.
• Its role in chronic liver diseases, particularly liver cirrhosis, requires further elucidation.
• Understanding FN's involvement can aid in assessing disease progression and liver function.

Purpose of the Study:

• To evaluate the role of fibronectin (FN) in chronic liver diseases.
• To assess the correlation between plasma FN levels and liver function parameters.
• To investigate the relationship between FN and markers of fibrogenesis and spleen volume.

Main Methods:

• Plasma FN concentrations were measured in 172 patients with chronic persistent hepatitis (CPH), chronic active hepatitis (CAH), and liver cirrhosis (LC).
• Patients were categorized by disease severity and Child-Pugh classification.
• Correlations were analyzed between FN levels and liver function tests, fibrogenesis markers (laminin, PIIINP), and spleen volume.

Main Results:

• Significantly reduced plasma FN levels were observed in liver cirrhosis (LC) patients compared to controls, CPH, and CAH groups.
• Lower FN values were noted in advanced LC stages (Child-Pugh B and C).
• In CAH, FN correlated with cholestasis markers; in LC, it correlated with synthesis and necrosis markers. A negative correlation with spleen volume was also found.

Conclusions:

• Plasma fibronectin levels are significantly reduced in liver cirrhosis, particularly in advanced stages.
• FN levels correlate with specific liver function parameters, reflecting cholestasis, synthesis, and necrosis in different chronic liver disease stages.
• Fibronectin may serve as a potential biomarker in chronic liver disease, though not directly correlated with fibrosis markers in this study.